Kelly Cosgrove - Publications

Affiliations: 
Yale University, New Haven, CT 

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Hillmer AT, Kloczynski T, Sandiego CM, Pittman B, Anderson JM, Labaree D, Gao H, Huang Y, Deluliis G, O'Malley SS, Carson RE, Cosgrove KP. Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol Abstinence. Alcoholism, Clinical and Experimental Research. PMID 26971694 DOI: 10.1111/acer.12997  0.32
2015 Hillmer AT, Mason GF, Fucito LM, O'Malley SS, Cosgrove KP. How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal. Alcoholism, Clinical and Experimental Research. PMID 26510169 DOI: 10.1111/acer.12893  0.32
2015 Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, Matuskey D, Lee JY, O'Connor KC, Huang Y, Carson RE, Hannestad J, Cosgrove KP. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proceedings of the National Academy of Sciences of the United States of America. PMID 26385967 DOI: 10.1073/pnas.1511003112  0.32
2015 Bois F, Gallezot JD, Zheng MQ, Lin SF, Esterlis I, Cosgrove KP, Carson RE, Huang Y. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates. Nuclear Medicine and Biology. 42: 570-7. PMID 25858513 DOI: 10.1016/j.nucmedbio.2014.08.003  0.32
2015 Verplaetse TL, Weinberger AH, Smith PH, Cosgrove KP, Mineur YS, Picciotto MR, Mazure CM, McKee SA. Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 17: 486-95. PMID 25762760 DOI: 10.1093/ntr/ntu280  0.32
2015 Weinberger AH, Smith PH, Allen SS, Cosgrove KP, Saladin ME, Gray KM, Mazure CM, Wetherington CL, McKee SA. Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 17: 407-21. PMID 25762750 DOI: 10.1093/ntr/ntu249  0.32
2015 Cosgrove KP, Veldhuizen MG, Sandiego CM, Morris ED, Small DM. Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum. Synapse (New York, N.Y.). 69: 195-202. PMID 25664726 DOI: 10.1002/syn.21809  0.32
2015 Cosgrove KP, Esterlis I, Sandiego C, Petrulli R, Morris ED. Imaging Tobacco Smoking with PET and SPECT. Current Topics in Behavioral Neurosciences. 24: 1-17. PMID 25638332 DOI: 10.1007/978-3-319-13482-6_1  0.32
2015 Yoder KK, Territo PR, Hutchins GD, Hannestad J, Morris ED, Gallezot JD, Normandin MD, Cosgrove KP. Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C]PBR28 brain uptake. Nuclear Medicine and Biology. 42: 305-8. PMID 25487553 DOI: 10.1016/j.nucmedbio.2014.11.003  0.32
2014 Cosgrove KP, Wang S, Kim SJ, McGovern E, Nabulsi N, Gao H, Labaree D, Tagare HD, Sullivan JM, Morris ED. Sex differences in the brain's dopamine signature of cigarette smoking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 16851-5. PMID 25505336 DOI: 10.1523/JNEUROSCI.3661-14.2014  0.32
2014 Cosgrove KP, McKay R, Esterlis I, Kloczynski T, Perkins E, Bois F, Pittman B, Lancaster J, Glahn DC, O'Malley S, Carson RE, Krystal JH. Tobacco smoking interferes with GABAA receptor neuroadaptations during prolonged alcohol withdrawal. Proceedings of the National Academy of Sciences of the United States of America. 111: 18031-6. PMID 25453062 DOI: 10.1073/pnas.1413947111  0.32
2014 Isaias IU, Spiegel J, Brumberg J, Cosgrove KP, Marotta G, Oishi N, Higuchi T, Küsters S, Schiller M, Dillmann U, van Dyck CH, Buck A, Herrmann K, Schloegl S, Volkmann J, et al. Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease. Frontiers in Aging Neuroscience. 6: 213. PMID 25177294 DOI: 10.3389/fnagi.2014.00213  0.32
2014 Gallezot JD, Esterlis I, Bois F, Zheng MQ, Lin SF, Kloczynski T, Krystal JH, Huang Y, Sabri O, Carson RE, Cosgrove KP. Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys. Synapse (New York, N.Y.). 68: 556-64. PMID 25043426 DOI: 10.1002/syn.21767  0.32
2014 Kim SJ, Sullivan JM, Wang S, Cosgrove KP, Morris ED. Voxelwise lp-ntPET for detecting localized, transient dopamine release of unknown timing: sensitivity analysis and application to cigarette smoking in the PET scanner. Human Brain Mapping. 35: 4876-91. PMID 24700424 DOI: 10.1002/hbm.22519  0.32
2014 Morris ED, Lucas MV, Petrulli JR, Cosgrove KP. How to design PET experiments to study neurochemistry: application to alcoholism. The Yale Journal of Biology and Medicine. 87: 33-54. PMID 24600335  0.32
2014 Esterlis I, Ranganathan M, Bois F, Pittman B, Picciotto MR, Shearer L, Anticevic A, Carlson J, Niciu MJ, Cosgrove KP, D'Souza DC. In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia. Biological Psychiatry. 76: 495-502. PMID 24360979 DOI: 10.1016/j.biopsych.2013.11.001  0.32
2014 Gallezot JD, Kloczynski T, Weinzimmer D, Labaree D, Zheng MQ, Lim K, Rabiner EA, Ridler K, Pittman B, Huang Y, Carson RE, Morris ED, Cosgrove KP. Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 866-74. PMID 24220025 DOI: 10.1038/npp.2013.286  0.32
2013 Sandiego CM, Jin X, Mulnix T, Fowles K, Labaree D, Ropchan J, Huang Y, Cosgrove K, Castner SA, Williams GV, Wells L, Rabiner EA, Carson RE. Awake nonhuman primate brain PET imaging with minimal head restraint: evaluation of GABAA-benzodiazepine binding with 11C-flumazenil in awake and anesthetized animals. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1962-8. PMID 24115528 DOI: 10.2967/jnumed.113.122077  0.32
2013 Morris ED, Kim SJ, Sullivan JM, Wang S, Normandin MD, Constantinescu CC, Cosgrove KP. Creating dynamic images of short-lived dopamine fluctuations with lp-ntPET: dopamine movies of cigarette smoking. Journal of Visualized Experiments : Jove. PMID 23963311 DOI: 10.3791/50358  0.32
2013 Hannestad JO, Cosgrove KP, DellaGioia NF, Perkins E, Bois F, Bhagwagar Z, Seibyl JP, McClure-Begley TD, Picciotto MR, Esterlis I. Changes in the cholinergic system between bipolar depression and euthymia as measured with [123I]5IA single photon emission computed tomography. Biological Psychiatry. 74: 768-76. PMID 23773793 DOI: 10.1016/j.biopsych.2013.04.004  0.32
2013 Esterlis I, Hannestad JO, Perkins E, Bois F, D'Souza DC, Tyndale RF, Seibyl JP, Hatsukami DM, Cosgrove KP, O'Malley SS. Effect of a nicotine vaccine on nicotine binding to β2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers. The American Journal of Psychiatry. 170: 399-407. PMID 23429725 DOI: 10.1176/appi.ajp.2012.12060793  0.32
2013 Sandiego CM, Nabulsi N, Lin SF, Labaree D, Najafzadeh S, Huang Y, Cosgrove K, Carson RE. Studies of the metabotropic glutamate receptor 5 radioligand [¹¹C]ABP688 with N-acetylcysteine challenge in rhesus monkeys. Synapse (New York, N.Y.). 67: 489-501. PMID 23424090 DOI: 10.1002/syn.21656  0.32
2013 Lee DE, Gallezot JD, Zheng MQ, Lim K, Ding YS, Huang Y, Carson RE, Morris ED, Cosgrove KP. Test-retest reproducibility of [11C]-(+)-propyl-hexahydro-naphtho-oxazin positron emission tomography using the bolus plus constant infusion paradigm. Molecular Imaging. 12: 77-82. PMID 23415395  0.32
2013 Tavares AA, Batis J, Barret O, Alagille D, Vala C, Kudej G, Koren A, Cosgrove KP, Nice K, Kordower JH, Seibyl J, Tamagnan GD. In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain. Nuclear Medicine and Biology. 40: 403-9. PMID 23332393 DOI: 10.1016/j.nucmedbio.2012.12.005  0.32
2013 Esterlis I, Hannestad JO, Bois F, Sewell RA, Tyndale RF, Seibyl JP, Picciotto MR, Laruelle M, Carson RE, Cosgrove KP. Imaging changes in synaptic acetylcholine availability in living human subjects. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 78-82. PMID 23160789 DOI: 10.2967/jnumed.112.111922  0.32
2013 Tavares AA, Barret O, Batis J, Alagille D, Koren A, Papin C, Kudej G, Nice K, Kordower JH, Cosgrove KP, Kloczynski T, Brenner E, Seibyl J, Tamagnan G. Kinetic modeling and occupancy measures of the norepinephrine transporters in baboons using single photon emission computed tomography with (123)I-INER. Synapse (New York, N.Y.). 67: 30-41. PMID 23042643 DOI: 10.1002/syn.21613  0.32
2013 Esterlis I, McKee SA, Kirk K, Lee D, Bois F, Stiklus SM, Seibyl JP, Krishnan-Sarin S, O'Malley SS, Staley JK, Cosgrove KP. Sex-specific differences in GABA(A) -benzodiazepine receptor availability: relationship with sensitivity to pain and tobacco smoking craving. Addiction Biology. 18: 370-8. PMID 22353491 DOI: 10.1111/j.1369-1600.2011.00403.x  0.32
2013 Lee DE, Gallezot JD, Zheng MQ, Lim K, Ding YS, Huang Y, Carson RE, Morris ED, Cosgrove KP. Test-retest reproducibility of [11C]-(+)-propyl-hexahydro- naphtho-oxazin positron emission tomography using the bolus plus constant infusion paradigm Molecular Imaging. 12: 1-6. DOI: 10.2310/7290.2012.00025  0.32
2012 Batis J, Barret O, Alagille D, Koren AO, Stehouwer JS, Cosgrove K, Goodman M, Seibyl J, Tamagnan G. In vivo evaluation of [¹²³I]mZIENT as a SPECT radioligand for the serotonin transporter. Nuclear Medicine and Biology. 39: 1137-41. PMID 23084043 DOI: 10.1016/j.nucmedbio.2012.07.006  0.32
2012 Hannestad J, Gallezot JD, Schafbauer T, Lim K, Kloczynski T, Morris ED, Carson RE, Ding YS, Cosgrove KP. Endotoxin-induced systemic inflammation activates microglia: [¹¹C]PBR28 positron emission tomography in nonhuman primates. Neuroimage. 63: 232-9. PMID 22776451 DOI: 10.1016/j.neuroimage.2012.06.055  0.32
2012 Saricicek A, Esterlis I, Maloney KH, Mineur YS, Ruf BM, Muralidharan A, Chen JI, Cosgrove KP, Kerestes R, Ghose S, Tamminga CA, Pittman B, Bois F, Tamagnan G, Seibyl J, et al. Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. The American Journal of Psychiatry. 169: 851-9. PMID 22772158 DOI: 10.1176/appi.ajp.2012.11101546  0.32
2012 Cosgrove KP, Esterlis I, McKee SA, Bois F, Seibyl JP, Mazure CM, Krishnan-Sarin S, Staley JK, Picciotto MR, O'Malley SS. Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Archives of General Psychiatry. 69: 418-27. PMID 22474108 DOI: 10.1001/archgenpsychiatry.2011.1465  0.32
2012 D'Souza DC, Esterlis I, Carbuto M, Krasenics M, Seibyl J, Bois F, Pittman B, Ranganathan M, Cosgrove K, Staley J. Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia. The American Journal of Psychiatry. 169: 326-34. PMID 22193533 DOI: 10.1176/appi.ajp.2011.11020189  0.32
2011 Xie P, Kranzler HR, Krauthammer M, Cosgrove KP, Oslin D, Anton RF, Farrer LA, Picciotto MR, Krystal JH, Zhao H, Gelernter J. Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biological Psychiatry. 70: 528-36. PMID 21683344 DOI: 10.1016/j.biopsych.2011.04.017  0.32
2011 Cosgrove KP, Kloczynski T, Nabulsi N, Weinzimmer D, Lin SF, Staley JK, Bhagwagar Z, Carson RE. Assessing the sensitivity of [¹¹C]p943, a novel 5-HT1B radioligand, to endogenous serotonin release. Synapse (New York, N.Y.). 65: 1113-7. PMID 21484884 DOI: 10.1002/syn.20942  0.32
2011 Cosgrove KP, Esterlis I, Mason GF, Bois F, O'Malley SS, Krystal JH. Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence. Neuropharmacology. 60: 1318-25. PMID 21276806 DOI: 10.1016/j.neuropharm.2011.01.020  0.32
2011 Esterlis I, Mitsis EM, Batis JC, Bois F, Picciotto MR, Stiklus SM, Kloczynski T, Perry E, Seibyl JP, McKee S, Staley JK, Cosgrove KP. Brain β2*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 389-98. PMID 21029513 DOI: 10.1017/S1461145710001227  0.32
2011 Walderhaug E, Cosgrove KP, Bhagwagar Z, Neumeister A. The relationship between mood, stress, and tobacco smoking Brain Imaging in Behavioral Medicine and Clinical Neuroscience. 147-161. DOI: 10.1007/978-1-4419-6373-4_10  0.32
2010 Cosgrove KP. Imaging receptor changes in human drug abusers. Current Topics in Behavioral Neurosciences. 3: 199-217. PMID 21161754 DOI: 10.1007/7854_2009_24  0.32
2010 Cosgrove KP, Tellez-Jacques K, Pittman B, Petrakis I, Baldwin RM, Tamagnan G, Seibyl J, Kosten T, Staley JK. Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging study. Psychiatry Research. 184: 192-5. PMID 21050726 DOI: 10.1016/j.pscychresns.2010.08.001  0.32
2010 Esterlis I, Cosgrove KP, Batis JC, Bois F, Stiklus SM, Perkins E, Seibyl JP, Carson RE, Staley JK. Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1226-33. PMID 20660383 DOI: 10.2967/jnumed.109.072447  0.32
2010 Cosgrove KP, Staley JK, Baldwin RM, Bois F, Plisson C, Al-Tikriti MS, Seibyl JP, Goodman MM, Tamagnan GD. SPECT imaging with the serotonin transporter radiotracer [123I]p ZIENT in nonhuman primate brain. Nuclear Medicine and Biology. 37: 587-91. PMID 20610163 DOI: 10.1016/j.nucmedbio.2010.03.007  0.32
2010 Cosgrove KP, Esterlis I, McKee S, Bois F, Alagille D, Tamagnan GD, Seibyl JP, Krishnan-Sarin S, Staley JK. Beta2* nicotinic acetylcholine receptors modulate pain sensitivity in acutely abstinent tobacco smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 535-9. PMID 20371741 DOI: 10.1093/ntr/ntq040  0.32
2010 Cosgrove KP, Kloczynski T, Bois F, Pittman B, Tamagnan G, Seibyl JP, Krystal JH, Staley JK. Decreased Beta(2)*-nicotinic acetylcholine receptor availability after chronic ethanol exposure in nonhuman primates. Synapse (New York, N.Y.). 64: 729-32. PMID 20340174 DOI: 10.1002/syn.20795  0.32
2010 Esterlis I, Cosgrove KP, Petrakis IL, McKee SA, Bois F, Krantzler E, Stiklus SM, Perry EB, Tamagnan GD, Seibyl JP, Krystal JH, Staley JK. SPECT imaging of nicotinic acetylcholine receptors in nonsmoking heavy alcohol drinking individuals. Drug and Alcohol Dependence. 108: 146-50. PMID 20074869 DOI: 10.1016/j.drugalcdep.2009.12.006  0.32
2009 Esterlis I, Cosgrove KP, Batis JC, Bois F, Kloczynski TA, Stiklus SM, Perry E, Tamagnan GD, Seibyl JP, Makuch R, Krishnan-Sarin S, O'Malley S, Staley JK. GABAA-benzodiazepine receptor availability in smokers and nonsmokers: relationship to subsyndromal anxiety and depression. Synapse (New York, N.Y.). 63: 1089-99. PMID 19642218 DOI: 10.1002/syn.20688  0.32
2009 Cosgrove KP, Batis J, Bois F, Maciejewski PK, Esterlis I, Kloczynski T, Stiklus S, Krishnan-Sarin S, O'Malley S, Perry E, Tamagnan G, Seibyl JP, Staley JK. beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Archives of General Psychiatry. 66: 666-76. PMID 19487632 DOI: 10.1001/archgenpsychiatry.2009.41  0.32
2009 Cosgrove KP, Krantzler E, Frohlich EB, Stiklus S, Pittman B, Tamagnan GD, Baldwin RM, Bois F, Seibyl JP, Krystal JH, O'Malley SS, Staley JK. Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smoking. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2218-26. PMID 19440191 DOI: 10.1038/npp.2009.49  0.32
2009 Hausner SH, Alagille D, Koren AO, Amici L, Staley JK, Cosgrove KP, Baldwin RM, Tamagnan GD. Synthesis of 5- and 6-substituted 2-(4-dimethylaminophenyl)-1,3-benzoxazoles and their in vitro and in vivo evaluation as imaging agents for amyloid plaque. Bioorganic & Medicinal Chemistry Letters. 19: 543-5. PMID 19081717 DOI: 10.1016/j.bmcl.2008.05.033  0.32
2009 Mitsis EM, Cosgrove KP, Staley JK, Bois F, Frohlich EB, Tamagnan GD, Estok KM, Seibyl JP, van Dyck CH. Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT. Neurobiology of Aging. 30: 1490-7. PMID 18242781 DOI: 10.1016/j.neurobiolaging.2007.12.008  0.32
2008 Alagille D, Koren AO, Kudej G, Staley J, Cosgrove K, Seibyl J, Tamagnan GD. 6-[123I]Iodo-2-[[4-(2-methoxyphenyl) piperazin-1-yl]methyl] imidazo[1,2-a]pyridine as potential SPECT agent for imaging dopamine D 4 receptor: Synthesis and in vivo evaluation in a nonhuman primate Journal of Labelled Compounds and Radiopharmaceuticals. 51: 202-206. DOI: 10.1002/jlcr.1500  0.32
2007 Cosgrove KP, Mitsis EM, Bois F, Frohlich E, Tamagnan GD, Krantzler E, Perry E, Maciejewski PK, Epperson CN, Allen S, O'malley S, Mazure CM, Seibyl JP, van Dyck CH, Staley JK. 123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1633-40. PMID 17873128 DOI: 10.2967/jnumed.107.042317  0.32
2007 Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biological Psychiatry. 62: 847-55. PMID 17544382 DOI: 10.1016/j.biopsych.2007.03.001  0.32
2007 Mitsis EM, Cosgrove KP, Staley JK, Frohlich EB, Bois F, Tamagnan GD, Estok KM, Seibyl JP, Van Dyck CH. [123I]5-IA-85380 SPECT imaging of beta2-nicotinic acetylcholine receptor availability in the aging human brain. Annals of the New York Academy of Sciences. 1097: 168-70. PMID 17413019 DOI: 10.1196/annals.1379.015  0.32
2006 Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, Dubin JA, Estok K, Brenner E, Baldwin RM, Tamagnan GD, Seibyl JP, Jatlow P, Picciotto MR, London ED, et al. Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 8707-14. PMID 16928859 DOI: 10.1523/JNEUROSCI.0546-06.2006  0.32
2004 Roth ME, Cosgrove KP, Carroll ME. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neuroscience and Biobehavioral Reviews. 28: 533-46. PMID 15527861 DOI: 10.1016/j.neubiorev.2004.08.001  0.32
2004 Cosgrove KP, Carroll ME. Differential effects of bremazocine on oral phencyclidine (PCP) self-administration in male and female rhesus monkeys. Experimental and Clinical Psychopharmacology. 12: 111-7. PMID 15122955 DOI: 10.1037/1064-1297.12.2.111  0.32
2004 Carroll ME, Lynch WJ, Roth ME, Morgan AD, Cosgrove KP. Sex and estrogen influence drug abuse. Trends in Pharmacological Sciences. 25: 273-9. PMID 15120494 DOI: 10.1016/j.tips.2004.03.011  0.32
2003 Cosgrove KP, Carroll ME. Effects of a non-drug reinforcer, saccharin, on oral self-administration of phencyclidine in male and female rhesus monkeys. Psychopharmacology. 170: 9-16. PMID 12838382 DOI: 10.1007/s00213-003-1487-x  0.32
2002 Cosgrove KP, Hunter RG, Carroll ME. Wheel-running attenuates intravenous cocaine self-administration in rats: sex differences. Pharmacology, Biochemistry, and Behavior. 73: 663-71. PMID 12151042 DOI: 10.1016/S0091-3057(02)00853-5  0.32
2002 Cosgrove KP, Carroll ME. Effects of bremazocine on self-administration of smoked cocaine base and orally delivered ethanol, phencyclidine, saccharin, and food in rhesus monkeys: a behavioral economic analysis. The Journal of Pharmacology and Experimental Therapeutics. 301: 993-1002. PMID 12023530 DOI: 10.1124/jpet.301.3.993  0.32
2002 Bernstein GA, Carroll ME, Thuras PD, Cosgrove KP, Roth ME. Caffeine dependence in teenagers. Drug and Alcohol Dependence. 66: 1-6. PMID 11850129  0.32
2000 Carroll ME, Cosgrove KP, Campbell UC, Morgan AD, Mickelberg JL. Reductions in ethanol, phencyclidine, and food-maintained behavior by naltrexone pretreatment in monkeys is enhanced by open economic conditions. Psychopharmacology. 148: 412-22. PMID 10928315  0.32
1999 Rodefer JS, Campbell UC, Cosgrove KP, Carroll ME. Naltrexone pretreatment decreases the reinforcing effectiveness of ethanol and saccharin but not PCP or food under concurrent progressive-ratio schedules in rhesus monkeys. Psychopharmacology. 141: 436-46. PMID 10090652 DOI: 10.1007/s002130050854  0.32
Show low-probability matches.